Monitoring mycophenolate mofetil is necessary for the effective prophylaxis of acute GVHD after cord blood transplantation

Bone Marrow Transplant. 2015 Feb;50(2):312-4. doi: 10.1038/bmt.2014.258. Epub 2014 Nov 10.

Authors

Y Arai¹, T Kondo¹, T Kitano¹, M Hishizawa¹, K Yamashita¹, N Kadowaki¹, T Yamamoto², I Yano², K Matsubara², A Takaori-Kondo¹

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.

PMID: 25387096
DOI: 10.1038/bmt.2014.258

No abstract available

Publication types

Clinical Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Adolescent
Adult
Aged
Allografts
Cord Blood Stem Cell Transplantation*
Drug Monitoring*
Female
Graft vs Host Disease / prevention & control*
Humans
Immunosuppressive Agents* / administration & dosage
Immunosuppressive Agents* / blood
Leukemia* / blood
Leukemia* / therapy
Lymphoma* / blood
Lymphoma* / therapy
Male
Middle Aged
Mycophenolic Acid / administration & dosage
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / pharmacokinetics

Substances

Immunosuppressive Agents
Mycophenolic Acid